Ravi is as an Investment Executive responsible for evaluating and executing transactions, as well as supporting the origination of investment opportunities. Ravi worked on our investment in MYCOM OSI.
Prior to joining Inflexion in September 2018, Ravi spent four years at Rothschild, working within the Healthcare M&A team. He completed a number of high-profile transactions in both the pharmaceuticals and healthcare services spaces, including the sale of Oasis Dental Care to BUPA and the acquisition of Compeed by HRA Pharma.
Outside of work, Ravi is a sports enthusiast and enjoys spending his free time watching and playing a variety of sports (particularly football and tennis). Ravi is also a keen traveller and likes to visit new places and discover new cuisines.
Ravi graduated with a degree in Economics from Cambridge University in 2014.